Courier Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Courier Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Hold	2,485	–	–	0.02%	318
2026 Q1	$317K	Buy	2,485 +165	+7%	+$20.6K	0.02%	322
2025 Q4	$283K	Buy	+2,320	New	+$266K	0.02%	334
2024 Q4	–	Sell	-3,000	Closed	-$296K	–	383
2024 Q3	$296K	Sell	3,000 -125	-4%	-$12.3K	0.02%	297
2024 Q2	$290K	Sell	3,125 -1,475	-32%	-$132K	0.02%	284
2024 Q1	$436K	Sell	4,600 -750	-14%	-$69.6K	0.03%	257
2023 Q4	$478K	Sell	5,350 -405	-7%	-$30.1K	0.04%	242
2023 Q3	$420K	Hold	5,755	–	–	0.03%	252
2023 Q2	$479K	Sell	5,755 -16,355	-74%	-$1.37M	0.04%	248
2023 Q1	$1.69M	Sell	22,110 -850	-4%	-$70.5K	0.19%	95
2022 Q4	$1.91M	Sell	22,960 -2,495	-10%	-$202K	0.22%	91
2022 Q3	$2.02M	Sell	25,455 -552	-2%	-$46.5K	0.25%	89
2022 Q2	$1.93M	Sell	26,007 -318	-1%	-$23.9K	0.23%	94
2022 Q1	$2.37M	Sell	26,325 -3,470	-12%	-$320K	0.24%	87
2021 Q4	$3.34M	Sell	29,795 -1,130	-4%	-$136K	0.31%	74
2021 Q3	$3.89M	Sell	30,925 -225	-0.7%	-$29K	0.37%	64
2021 Q2	$4.22M	Sell	31,150 -290	-0.9%	-$38.1K	0.4%	61
2021 Q1	$4.26M	Sell	31,440 -325	-1%	-$48.7K	0.43%	54
2020 Q4	$4.47M	Hold	31,765	–	–	0.49%	44
2020 Q3	$3.81M	Sell	31,765 -1,625	-5%	-$182K	0.46%	49
2020 Q2	$3.77M	Sell	33,390 -575	-2%	-$56.6K	0.49%	44
2020 Q1	$3.13M	Sell	33,965 -11,975	-26%	-$1.06M	0.46%	51
2019 Q4	$4.4M	Sell	45,940 -875	-2%	-$75.7K	0.52%	45
2019 Q3	$3.59M	Buy	46,815 +100	+0.2%	+$8.31K	0.47%	50
2019 Q2	$4.1M	Buy	46,715 +100	+0.2%	+$8.53K	0.52%	45
2019 Q1	$4.22M	Sell	46,615 -200	-0.4%	-$17K	0.55%	45
2018 Q4	$3.36M	Sell	46,815 -700	-1%	-$56.4K	0.49%	48
2018 Q3	$4.55M	Sell	47,515 -400	-0.8%	-$38.8K	0.56%	45
2018 Q2	$4.56M	Sell	47,915 -1,550	-3%	-$142K	0.59%	41
2018 Q1	$4.34M	Sell	49,465 -500	-1%	-$45.6K	0.57%	45
2017 Q4	$4.24M	Sell	49,965 -1,535	-3%	-$129K	0.54%	49
2017 Q3	$4.46M	Buy	+51,500	New	+$4.13M	0.62%	42

Other funds holding XBI

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Courier Capital's XBI Position: Q2 2026 in Review

Courier Capital held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,485 shares worth $393K. The position accounts for 0.02% of the portfolio, ranked #318.

Courier Capital first reported a position in XBI in Q3 2017 and has held it in 32 quarters since. The position peaked at $4.56M in Q2 2018. 380 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Courier Capital held 2,485 shares of State Street SPDR S&P Biotech ETF worth $393K as of Q2 2026.
Courier Capital left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Courier Capital's portfolio in Q2 2026, its #318 holding.
Courier Capital first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and has held it in 32 quarters since.
Courier Capital's State Street SPDR S&P Biotech ETF position peaked at $4.56M in Q2 2018.
380 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.